Your browser doesn't support javascript.
loading
Changes in weight among individuals with psychiatric conditions or socioeconomic disadvantage assigned to smoke very low nicotine content cigarettes.
Harfmann, Roxanne F; Heil, Sarah H; Bunn, Janice Y; Snell, L Morgan; Tidey, Jennifer W; Sigmon, Stacey C; Gaalema, Diann E; Lee, Dustin C; Streck, Joanna M; Bergeria, Cecilia L; Davis, Danielle R; Plucinski, Shirley; Higgins, Stephen T.
Affiliation
  • Harfmann RF; Department of Psychiatry, Vermont Center on Behavior and Health, University of Vermont.
  • Heil SH; Department of Psychiatry, Vermont Center on Behavior and Health, University of Vermont.
  • Bunn JY; Department of Psychiatry, Vermont Center on Behavior and Health, University of Vermont.
  • Snell LM; Department of Behavioral and Social Sciences, Brown University.
  • Tidey JW; Department of Behavioral and Social Sciences, Brown University.
  • Sigmon SC; Department of Psychiatry, Vermont Center on Behavior and Health, University of Vermont.
  • Gaalema DE; Department of Psychiatry, Vermont Center on Behavior and Health, University of Vermont.
  • Lee DC; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University.
  • Streck JM; Department of Psychiatry, Harvard Medical School.
  • Bergeria CL; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University.
  • Davis DR; Department of Psychiatry, Yale University.
  • Plucinski S; Department of Psychiatry, Vermont Center on Behavior and Health, University of Vermont.
  • Higgins ST; Department of Psychiatry, Vermont Center on Behavior and Health, University of Vermont.
Exp Clin Psychopharmacol ; 32(2): 181-188, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38236223
ABSTRACT
Nicotine abstinence leads to weight gain, which could be an unintended consequence of a nicotine reduction policy. This secondary analysis used weekly assessments of weight and ratings of "increased appetite/hunger/weight gain" collected in three 12-week, randomized controlled trials evaluating the effects of cigarettes differing in nicotine dose (15.8, 2.4, or 0.4 mg/g) among individuals with affective disorders, opioid use disorder (OUD), and socioeconomically disadvantaged women. Linear mixed models tested differences by dose and time. Analyses first collapsed across populations and then separated out individuals with OUD because biomarkers suggested they used substantially more noncombusted nicotine. Across populations, weight increased significantly over time, averaging 1.03 kg (p < .001), but did not vary by dose nor was there any interaction of dose/time. "Increased appetite/hunger/weight gain" ratings increased significantly as a function of dose, with differences between low and high doses (1.95 and 1.73, respectively, p = .01), but not by time nor any interaction. In the combined group of individuals with affective disorders and socioeconomically disadvantaged women, weight and "increased appetite/hunger/weight gain" ratings increased significantly by dose, with differences between low and high doses (1.43 vs. 0.73 kg, p = .003 and 2.00 vs. 1.76, p = .02, respectively). Among individuals with OUD, there were no significant effects of any kind on either outcome. Individuals with affective disorders and socioeconomically disadvantaged women gained weight and reported more subjective appetite/weight gain when given 0.4, but not 2.4 mg/g cigarettes, despite comparable decreases in nicotine exposure. However, neither change was clinically significant, suggesting minimal short-term adverse consequences of a nicotine reduction policy. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Smoking Cessation / Tobacco Products / Opioid-Related Disorders Type of study: Clinical_trials Aspects: Determinantes_sociais_saude / Equity_inequality Limits: Female / Humans Language: En Journal: Exp Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Smoking Cessation / Tobacco Products / Opioid-Related Disorders Type of study: Clinical_trials Aspects: Determinantes_sociais_saude / Equity_inequality Limits: Female / Humans Language: En Journal: Exp Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2024 Document type: Article Country of publication: United States